Maxim Group Maintains Biorestorative Therapies(BRTX.US) With Buy Rating, Maintains Target Price $6

Futu NewsNov 15 03:32 · Ratings

Positive Outlook for BioRestorative Therapies: Phase 2 Trial Results Drive Buy Rating

TipRanksNov 15 02:55 · Ratings

Roth MKM Remains a Buy on BioRestorative Therapies (BRTX)

TipRanksNov 14 21:11 · Ratings

BioRestorative Therapies, Inc. (BRTX) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 14 09:14 · Conference Call

BioRestorative Therapies Showcases Promising Stem Cell Advances

TipRanksNov 14 05:44

Biorestorative Therapies | 8-K: BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update

SECNov 14 05:14